Luye Pharma Group Announces Major Investment Deal
PremiumCompany AnnouncementsLuye Pharma Group Announces Major Investment Deal
2M ago
Luye Pharma’s New Pain Drug Approved in China
Premium
Company Announcements
Luye Pharma’s New Pain Drug Approved in China
3M ago
Luye Pharma’s LY03010 Clears FDA Inspection
Premium
Company Announcements
Luye Pharma’s LY03010 Clears FDA Inspection
3M ago
Luye Pharma downgraded to Sell from Neutral at Goldman Sachs
PremiumThe FlyLuye Pharma downgraded to Sell from Neutral at Goldman Sachs
9M ago
Luye Pharma upgraded to Neutral from Underperform at Credit Suisse
Premium
The Fly
Luye Pharma upgraded to Neutral from Underperform at Credit Suisse
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100